Clinical Trial Update: A Study: Pure CBD as Single-agent for Solid Tumor. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pure cannabidiol (CBD) as a single agent for solid tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pure CBD (cannabidiol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Solid Tumor | Phase 2 | Status: UNKNOWN